Advertisement
Screener

Enlivex Ltd. (ENLV) Form 6-K: Report of foreign private issuer, 2020

Enlivex Ltd. Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2020-12-21: Form 6-K; Period of report 2020-12-21; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea131982-6k_enlivextherap.htm.
  • 2020-12-07: Form 6-K; Period of report 2020-12-07; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea131111-6k_enlivextherap.htm.
  • 2020-12-03: Form 6-K; Period of report 2020-12-03; Description FORM 6-K; Document ea130896-6k_enlivex.htm.
  • 2020-11-18: Form 6-K; Period of report 2020-11-18; Description FORM 6-K; Document ea130075-6k_enlivexthera.htm.
FiledFormPeriod of reportDescriptionDocument
2020-12-216-K2020-12-21REPORT OF FOREIGN PRIVATE ISSUERea131982-6k_enlivextherap.htm
2020-12-076-K2020-12-07REPORT OF FOREIGN PRIVATE ISSUERea131111-6k_enlivextherap.htm
2020-12-036-K2020-12-03FORM 6-Kea130896-6k_enlivex.htm
2020-11-186-K2020-11-18FORM 6-Kea130075-6k_enlivexthera.htm
2020-11-176-K2020-11-17REPORT OF FOREIGN PRIVATE ISSUERea129902-6k_enlivextherap.htm
2020-11-126-K2020-11-12FORM 6-Kea129646-6k_enlivexthera.htm
2020-11-056-K2020-11-05FORM 6-Kea129357-6k_enlivex.htm
2020-11-036-K2020-11-03FORM 6-Kea129285-6k_enlivex.htm
2020-10-306-K2020-10-30REPORT OF FOREIGN PRIVATE ISSUERea129185-6k_enlivextherap.htm
2020-10-276-K2020-10-27REPORT OF FOREIGN PRIVATE ISSUERea128966-6k_enlivex.htm
2020-10-226-K2020-10-22FORM 6-Kea128695-6k_enlivexthera.htm
2020-10-226-K2020-10-22REPORT OF FOREIGN PRIVATE ISSUERea128735-6k_enlivexthera.htm
2020-10-136-K2020-10-13REPORT OF FOREIGN PRIVATE ISSUERea128107-6k_enlivexthera.htm
2020-10-136-K/A2020-06-30AMENDMENT TO 6-Kea128095-6ka_enlivextherap.htm
2020-10-016-K2020-10-01FORM 6-Kea127610-6k_enlivexthera.htm
2020-09-166-K2020-09-16REPORT OF FOREIGN PRIVATE ISSUERea126871-6k_enlivexthera.htm
2020-08-256-K2020-08-25REPORT OF FOREIGN PRIVATE ISSUERea125977-6k_enlivex.htm
2020-08-146-K2020-08-14REPORT OF FOREIGN PRIVATE ISSUERea125188-6k_enlivex.htm
2020-08-106-K2020-08-10REPORT OF FOREIGN PRIVATE ISSUERea125249-6k_enlivextherape.htm
2020-06-296-K2020-06-29REPORT OF FOREIGN PRIVATE ISSUERea123539-6k_enlivextherap.htm
2020-06-186-K2020-06-18FORM 6-Kf6k061820_enlivex.htm
2020-06-156-K2020-06-15REPORT OF FOREIGN PRIVATE ISSUERea123034-6k_enlivextherap.htm
2020-05-286-K2020-05-28REPORT OF FOREIGN PRIVATE ISSUERea122415-6k_enlivextherap.htm
2020-05-196-K2020-05-19FORM 6-Kea121533-6k_enlivextherap.htm
2020-05-186-K2020-05-18REPORT OF FOREIGN PRIVATE ISSUERea121968-6k_enlivextherap.htm
2020-05-076-K2020-05-07FORM 6-Kea121472-6k_enlivexthera.htm
2020-04-136-K2020-04-13REPORT OF FOREIGN PRIVATE ISSUERea120608-6k_enlivextherap.htm
2020-03-186-K2020-03-18CURRENT REPORT OF FOREIGN ISSUERea119753-6k_enlivex.htm
2020-03-056-K2020-03-05REPORT OF FOREIGN PRIVATE ISSUERea119269-6k_enlivextherape.htm
2020-02-266-K2020-02-26REPORT OF FOREIGN PRIVATE ISSUERea119024-6k_enlivex.htm
2020-02-246-K2020-02-24REPORT OF FOREIGN PRIVATE ISSUERf6k022420_enlivex.htm